ישראל -
עברית -
Ministry of Health
לנלידומיד אס.קיי. 7.5 מג
k.s.kim international (sk- pharma) ltd., israel - lenalidomide - קפסולה קשיחה - lenalidomide 7.5 mg - lenalidomide
ישראל -
עברית -
Ministry of Health
לנלידומיד אס.קיי.15 מג
k.s.kim international (sk- pharma) ltd., israel - lenalidomide - קפסולה קשיחה - lenalidomide 15 mg - lenalidomide
ישראל -
עברית -
Ministry of Health
לנלידומיד אס.קיי.20 מג
k.s.kim international (sk- pharma) ltd., israel - lenalidomide - קפסולה קשיחה - lenalidomide 20 mg - lenalidomide
ישראל -
עברית -
Ministry of Health
קלטרה תמיסה לשתייה
abbvie biopharmaceuticals ltd, israel - lopinavir; ritonavir - תמיסה (פומי) - ritonavir 20 mg/ml; lopinavir 80 mg/ml - ritonavir - ritonavir - kaletra is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection.
ישראל -
עברית -
Ministry of Health
קלטרה 100 מג25 מג טבליות
abbvie biopharmaceuticals ltd, israel - lopinavir; ritonavir - טבליות מצופות פילם - lopinavir 100 mg; ritonavir 25 mg - ritonavir - ritonavir - kaletra is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infections.
ישראל -
עברית -
Ministry of Health
קלטרה 200 מג50 מג טבליות
abbvie biopharmaceuticals ltd, israel - lopinavir; ritonavir - טבליות מצופות פילם - ritonavir 50 mg; lopinavir 200 mg - lopinavir - lopinavir - kaletra is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection.
ישראל -
עברית -
Ministry of Health
קלטרה 200 מג50 מג טבליות
abbvie biopharmaceuticals ltd, israel - lopinavir; ritonavir - טבליות מצופות פילם - ritonavir 50 mg; lopinavir 200 mg - lopinavir - lopinavir - kaletra is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection.
ישראל -
עברית -
Ministry of Health
רבלימיד 5 מ"ג
neopharm scientific ltd - lenalidomide 5 mg - capsules - lenalidomide - 1. treatment of patients with transfusion-dependent anemia due to low- or intermediate - 1 - risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormality. 2. in combination with dexamethasone treatment of multiple myeloma patient who have received at least one prior therapy.
ישראל -
עברית -
Ministry of Health
רבלימיד 10 מ"ג
neopharm scientific ltd - lenalidomide 10 mg - capsules - lenalidomide - 1. treatment of patients with transfusion-dependent anemia due to low- or intermediate - 1 - risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormality. 2. in combination with dexamethasone treatment of multiple myeloma patient who have received at least one prior therapy.
ישראל -
עברית -
Ministry of Health
רבלימיד 15 מ"ג
neopharm scientific ltd - lenalidomide 15 mg - capsules - lenalidomide - 1. treatment of patients with transfusion-dependent anemia due to low- or intermediate - 1 - risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormality. 2. in combination with dexamethasone treatment of multiple myeloma patient who have received at least one prior therapy.